Peter Falkai's main research interest is focused on the neurobiology of psychotic disorders, namely schizophrenia. He holds the position of Chair of the Department of Psychiatry and Psychotherapy of the University of Munich. Prof. Falkai has been leading multidisciplinary teams of researchers, allowing the use of techniques ranging from functional imaging to gene expression in human post-mortem-tissue. His clinical and research expertise focuses continuously on the neurobiological origins and pathomorphological aspects as well as on causal treatment options of psychotic disorders. Prof. Falkai has managed to obtain state funding for numerous of his research projects and has also received various research awards. He has been involved in creating treatment guidelines for schizophrenia for the German Society of Psychiatry, Psychotherapy and Nervous Diseases (DGPPN) and for the World Federation of the Biological Societies (WFSBP). He was Chairman of the DGPPN from 2011-2012 and is currently president-elect of the European Psychiatric Association (EPA).